echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Kangchen Pharmaceutical KC1036 entered the phase II clinical study of thymic tumor

    Kangchen Pharmaceutical KC1036 entered the phase II clinical study of thymic tumor

    • Last Update: 2023-02-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Beijing Kangchen Pharmaceutical Co.
    , Ltd.
    (hereinafter referred to as the "Company") recently announced the phase II clinical trial information
    of KC1036 for the treatment of advanced thymic tumor patients on the drug clinical trial registration and information disclosure platform of the State Medical Products Administration.
    This phase II clinical study has passed the review of the Clinical Trial Ethics Review Committee of West China Hospital of Sichuan University and the Ethics Committee of Shanghai Chest Hospital, and will officially start the recruitment of
    subjects in the near future.

    KC1036 tablets (hereinafter referred to as "KC1036") is a Class 1 innovative chemical drug independently developed by the company that is not on the market at home and abroad, and is intended for the treatment
    of solid tumors.

    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.